nodes	percent_of_prediction	percent_of_DWPC	metapath
Mifepristone—ABCC1—Rifampicin—leprosy	0.218	0.229	CbGbCtD
Mifepristone—CYP3A7—Rifampicin—leprosy	0.108	0.113	CbGbCtD
Mifepristone—CYP3A7-CYP3A51P—Rifampicin—leprosy	0.108	0.113	CbGbCtD
Mifepristone—CYP3A7—Dapsone—leprosy	0.0891	0.0933	CbGbCtD
Mifepristone—CYP3A7-CYP3A51P—Dapsone—leprosy	0.0891	0.0933	CbGbCtD
Mifepristone—CYP3A5—Thalidomide—leprosy	0.0836	0.0876	CbGbCtD
Mifepristone—CYP3A5—Rifampicin—leprosy	0.081	0.0848	CbGbCtD
Mifepristone—CYP3A5—Dapsone—leprosy	0.0668	0.07	CbGbCtD
Mifepristone—ABCB1—Rifampicin—leprosy	0.0527	0.0552	CbGbCtD
Mifepristone—CYP3A4—Rifampicin—leprosy	0.0316	0.0331	CbGbCtD
Mifepristone—CYP3A4—Dapsone—leprosy	0.0261	0.0273	CbGbCtD
Mifepristone—AR—scrotum—leprosy	0.00458	0.454	CbGeAlD
Mifepristone—Erythema nodosum—Thalidomide—leprosy	0.00235	0.0661	CcSEcCtD
Mifepristone—Metrorrhagia—Thalidomide—leprosy	0.00143	0.04	CcSEcCtD
Mifepristone—Nasopharyngitis—Dapsone—leprosy	0.00129	0.0363	CcSEcCtD
Mifepristone—Muscular weakness—Dapsone—leprosy	0.00127	0.0358	CcSEcCtD
Mifepristone—Sinusitis—Dapsone—leprosy	0.00104	0.0293	CcSEcCtD
Mifepristone—PGR—blood vessel—leprosy	0.000936	0.0928	CbGeAlD
Mifepristone—Rash maculo-papular—Thalidomide—leprosy	0.000925	0.026	CcSEcCtD
Mifepristone—Dermatitis exfoliative—Thalidomide—leprosy	0.000783	0.022	CcSEcCtD
Mifepristone—Hypoglycaemia—Thalidomide—leprosy	0.000757	0.0213	CcSEcCtD
Mifepristone—Pain in extremity—Thalidomide—leprosy	0.000739	0.0208	CcSEcCtD
Mifepristone—NR3C1—nerve—leprosy	0.000688	0.0682	CbGeAlD
Mifepristone—Hypokalaemia—Thalidomide—leprosy	0.000673	0.0189	CcSEcCtD
Mifepristone—Breast disorder—Thalidomide—leprosy	0.000668	0.0188	CcSEcCtD
Mifepristone—Toxic epidermal necrolysis—Thalidomide—leprosy	0.000666	0.0187	CcSEcCtD
Mifepristone—Cramp muscle—Thalidomide—leprosy	0.000666	0.0187	CcSEcCtD
Mifepristone—Muscular weakness—Thalidomide—leprosy	0.000652	0.0183	CcSEcCtD
Mifepristone—Insomnia—Dapsone—leprosy	0.000642	0.018	CcSEcCtD
Mifepristone—Gastrointestinal pain—Dapsone—leprosy	0.00058	0.0163	CcSEcCtD
Mifepristone—Infestation NOS—Thalidomide—leprosy	0.00057	0.016	CcSEcCtD
Mifepristone—Infestation—Thalidomide—leprosy	0.00057	0.016	CcSEcCtD
Mifepristone—Body temperature increased—Dapsone—leprosy	0.000561	0.0158	CcSEcCtD
Mifepristone—Abdominal pain—Dapsone—leprosy	0.000561	0.0158	CcSEcCtD
Mifepristone—Sinusitis—Thalidomide—leprosy	0.000534	0.015	CcSEcCtD
Mifepristone—Oedema peripheral—Thalidomide—leprosy	0.000504	0.0141	CcSEcCtD
Mifepristone—Angiopathy—Thalidomide—leprosy	0.000464	0.013	CcSEcCtD
Mifepristone—Mediastinal disorder—Thalidomide—leprosy	0.000461	0.0129	CcSEcCtD
Mifepristone—Chills—Thalidomide—leprosy	0.000459	0.0129	CcSEcCtD
Mifepristone—Vomiting—Dapsone—leprosy	0.000451	0.0127	CcSEcCtD
Mifepristone—Mental disorder—Thalidomide—leprosy	0.000448	0.0126	CcSEcCtD
Mifepristone—Malnutrition—Thalidomide—leprosy	0.000445	0.0125	CcSEcCtD
Mifepristone—Headache—Dapsone—leprosy	0.000445	0.0125	CcSEcCtD
Mifepristone—Back pain—Thalidomide—leprosy	0.000431	0.0121	CcSEcCtD
Mifepristone—Muscle spasms—Thalidomide—leprosy	0.000428	0.012	CcSEcCtD
Mifepristone—Nausea—Dapsone—leprosy	0.000421	0.0118	CcSEcCtD
Mifepristone—Ill-defined disorder—Thalidomide—leprosy	0.000413	0.0116	CcSEcCtD
Mifepristone—Angioedema—Thalidomide—leprosy	0.000407	0.0114	CcSEcCtD
Mifepristone—Malaise—Thalidomide—leprosy	0.000401	0.0113	CcSEcCtD
Mifepristone—Hypertension—Thalidomide—leprosy	0.000384	0.0108	CcSEcCtD
Mifepristone—Arthralgia—Thalidomide—leprosy	0.000379	0.0106	CcSEcCtD
Mifepristone—Myalgia—Thalidomide—leprosy	0.000379	0.0106	CcSEcCtD
Mifepristone—Anxiety—Thalidomide—leprosy	0.000378	0.0106	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000376	0.0106	CcSEcCtD
Mifepristone—Discomfort—Thalidomide—leprosy	0.000374	0.0105	CcSEcCtD
Mifepristone—Dry mouth—Thalidomide—leprosy	0.000371	0.0104	CcSEcCtD
Mifepristone—Oedema—Thalidomide—leprosy	0.000363	0.0102	CcSEcCtD
Mifepristone—Infection—Thalidomide—leprosy	0.000361	0.0101	CcSEcCtD
Mifepristone—Nervous system disorder—Thalidomide—leprosy	0.000356	0.01	CcSEcCtD
Mifepristone—Skin disorder—Thalidomide—leprosy	0.000353	0.00991	CcSEcCtD
Mifepristone—Anorexia—Thalidomide—leprosy	0.000346	0.00972	CcSEcCtD
Mifepristone—AR—skin of body—leprosy	0.000345	0.0342	CbGeAlD
Mifepristone—Hypotension—Thalidomide—leprosy	0.000339	0.00953	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Thalidomide—leprosy	0.000331	0.00929	CcSEcCtD
Mifepristone—Insomnia—Thalidomide—leprosy	0.000329	0.00923	CcSEcCtD
Mifepristone—Dyspnoea—Thalidomide—leprosy	0.000324	0.0091	CcSEcCtD
Mifepristone—Somnolence—Thalidomide—leprosy	0.000323	0.00907	CcSEcCtD
Mifepristone—Decreased appetite—Thalidomide—leprosy	0.000316	0.00887	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Thalidomide—leprosy	0.000314	0.00881	CcSEcCtD
Mifepristone—Fatigue—Thalidomide—leprosy	0.000313	0.0088	CcSEcCtD
Mifepristone—Constipation—Thalidomide—leprosy	0.000311	0.00872	CcSEcCtD
Mifepristone—Pain—Thalidomide—leprosy	0.000311	0.00872	CcSEcCtD
Mifepristone—Feeling abnormal—Thalidomide—leprosy	0.000299	0.00841	CcSEcCtD
Mifepristone—Gastrointestinal pain—Thalidomide—leprosy	0.000297	0.00834	CcSEcCtD
Mifepristone—ABCB1—blood vessel—leprosy	0.000289	0.0287	CbGeAlD
Mifepristone—Urticaria—Thalidomide—leprosy	0.000289	0.0081	CcSEcCtD
Mifepristone—NR3C1—eye—leprosy	0.000287	0.0285	CbGeAlD
Mifepristone—Abdominal pain—Thalidomide—leprosy	0.000287	0.00806	CcSEcCtD
Mifepristone—Body temperature increased—Thalidomide—leprosy	0.000287	0.00806	CcSEcCtD
Mifepristone—PGR—testis—leprosy	0.000273	0.0271	CbGeAlD
Mifepristone—PGR—nervous system—leprosy	0.000268	0.0266	CbGeAlD
Mifepristone—Hypersensitivity—Thalidomide—leprosy	0.000268	0.00752	CcSEcCtD
Mifepristone—AR—tendon—leprosy	0.000263	0.026	CbGeAlD
Mifepristone—Asthenia—Thalidomide—leprosy	0.000261	0.00732	CcSEcCtD
Mifepristone—Pruritus—Thalidomide—leprosy	0.000257	0.00722	CcSEcCtD
Mifepristone—NR3C1—skin of body—leprosy	0.00025	0.0248	CbGeAlD
Mifepristone—ABCC1—tendon—leprosy	0.00025	0.0247	CbGeAlD
Mifepristone—Diarrhoea—Thalidomide—leprosy	0.000249	0.00698	CcSEcCtD
Mifepristone—Dizziness—Thalidomide—leprosy	0.00024	0.00675	CcSEcCtD
Mifepristone—Vomiting—Thalidomide—leprosy	0.000231	0.00649	CcSEcCtD
Mifepristone—Rash—Thalidomide—leprosy	0.000229	0.00643	CcSEcCtD
Mifepristone—Dermatitis—Thalidomide—leprosy	0.000229	0.00643	CcSEcCtD
Mifepristone—Headache—Thalidomide—leprosy	0.000228	0.00639	CcSEcCtD
Mifepristone—AR—testis—leprosy	0.000218	0.0216	CbGeAlD
Mifepristone—Nausea—Thalidomide—leprosy	0.000216	0.00606	CcSEcCtD
Mifepristone—AR—nervous system—leprosy	0.000214	0.0212	CbGeAlD
Mifepristone—ABCC1—testis—leprosy	0.000207	0.0205	CbGeAlD
Mifepristone—NR3C1—tendon—leprosy	0.00019	0.0189	CbGeAlD
Mifepristone—NR3C1—testis—leprosy	0.000158	0.0156	CbGeAlD
Mifepristone—NR3C1—nervous system—leprosy	0.000155	0.0153	CbGeAlD
Mifepristone—CYP2D6—testis—leprosy	0.000117	0.0116	CbGeAlD
Mifepristone—CYP3A4—nervous system—leprosy	0.000117	0.0116	CbGeAlD
Mifepristone—CYP2D6—nervous system—leprosy	0.000115	0.0114	CbGeAlD
Mifepristone—ABCB1—testis—leprosy	8.44e-05	0.00836	CbGeAlD
Mifepristone—ABCB1—nervous system—leprosy	8.28e-05	0.00821	CbGeAlD
